India has had a sustained partnership with the Global Fund since 2002 both as a recipient and as a donor. So far, India has received $2.0 billion from the Global Fund for attaining targets related to HIV/AIDS, TB and Malaria reduction.
The Indian Government has pledged to eradicate TB by 2025, however this study warns that the TB epidemic could have lasting consequences for the treatment of lung conditions in India and across the globe.
A latent TB population is infected by the TB bacteria but the bacteria remains inactive, usually until the person’s immunity goes down. Shah estimates at least 40 to 50 per cent population in Mumbai is latent TB.
Tuberculosis, which is caused by a bacterium called Mycobacterium Tuberculosis, affects more than 10 million people every year and kills up to two million, making it the most deadly of the infectious diseases.
The researchers studied 200 healthcare workers comprising postgraduate medical residents and nursing students pursuing a bachelor’s degree at BJMC and Sassoon General Hospital (SGH) between May 2016 and December 2017.
Dr Gagandeep Kang, executive director of The Translational Health Science Technology Institute (THSTI) in Faridabad, Haryana, is the first woman Indian scientist and researcher to be elected as member of The Royal Society of London.